Primary central nervous system (CNS) vasculitis is a rare, frequently misdiagnosed condition that affects the brain and spinal cord and is characterized by a variety of neurologic symptoms at ...
Shutting down the enzyme PTP1B helps brain immune cells clear plaques again, pointing to a potential new Alzheimer’s ...
Panelists discuss how CNS-active EGFR TKIs are improving intracranial outcomes and influencing treatment selection in NSCLC. Panelists discuss how central nervous system (CNS) involvement in non–small ...
News Medical on MSN
FDA label update expands CAR T access for primary CNS lymphoma
Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system ...
ScienceAlert on MSN
Scientists Discover a Brain Circuit That Enhances Physical Endurance In Mice
The effects of exercise would not be nearly as powerful without the input of the brain, according to new research. A study on ...
MapLight Therapeutics is the latest biotech to want a turn with Alphabet’s AI spinout SandboxAQ. The neuro-focused company is penning a strategic collaboration meant to develop new therapies for ...
Eli Lilly has pulled out of the central nervous system (CNS)-focused portion of a $960 million biobucks deal centered on Rigel Pharmaceuticals’ receptor-interacting serine/threonine-protein kinase 1 ...
New Members of the Strengthened Leadership Team Add Decades of Operational Execution, Pipeline Optimization and Transactional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results